Published in Neuropsychopharmacology on August 17, 2016
Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine. J Neurosci (2017) 0.81
Sex differences in innate immunity and its impact on opioid pharmacology. J Neurosci Res (2017) 0.75
IL-1β levels are associated with chronic multisite pain in people living with HIV. J Acquir Immune Defic Syndr (2017) 0.75
Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol (2017) 0.75
Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats. Neuropsychopharmacology (2017) 0.75
Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats. Neurochem Res (2017) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron (1996) 7.20
A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 5.42
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep (2016) 3.70
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci (2005) 3.38
How opioids inhibit GABA-mediated neurotransmission. Nature (1997) 3.09
Endogenous pain control mechanisms: review and hypothesis. Ann Neurol (1978) 2.63
Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (1991) 2.63
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal (2007) 2.43
Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist (2004) 2.40
The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci (2002) 2.02
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun (2008) 1.92
Glia: novel counter-regulators of opioid analgesia. Trends Neurosci (2005) 1.86
Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A (2012) 1.80
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
The opioid-cytokine connection. J Neuroimmunol (1998) 1.52
Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science (2003) 1.48
Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol (2007) 1.41
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) (2013) 1.28
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem (1996) 1.27
Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol (2001) 1.25
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol Ther (2008) 1.19
Fez1 is layer-specifically expressed in the adult mouse neocortex. Eur J Neurosci (2004) 1.17
Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat. Eur J Neurosci (2008) 1.11
Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain (2006) 1.09
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Curr Opin Neurobiol (2014) 0.97
The elusive transporters with a high affinity for glutamate. Trends Neurosci (1993) 0.97
Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J Neurosci (2013) 0.97
Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth Analg (2010) 0.91
The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res (1997) 0.88
Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis. J Neuroimmunol (2015) 0.85
The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1. Arthritis Res Ther (2011) 0.84
Opioid tolerance--a predictor of increased length of stay and higher readmission rates. Pain Physician (2014) 0.83
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther (2011) 0.83
Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4. CNS Neurol Disord Drug Targets (2015) 0.82
Investigation of the role of TNF-α converting enzyme (TACE) in the inhibition of cell surface and soluble TNF-α production by acute ethanol exposure. PLoS One (2012) 0.80
Intrathecal etanercept partially restores morphine's antinociception in morphine-tolerant rats via attenuation of the glutamatergic transmission. Anesth Analg (2011) 0.78
Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF. Can J Anaesth (2002) 0.77